1-7 of 7
Thomas Schmidt
Close
Sort by
Journal Articles

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Mary Mansour Riwes, DO, Alexander Schmidt, Thomas Braun, John M. Magenau, MD, Attaphol Pawarode, Brian Parkin, Sarah Anand, MD, Monalisa Ghosh, John Maciejewski, Darren King, Muneesh Tewari, Sung W. Choi, Gregory A. Yanik, Kristi Maccready, Thomas Schmidt, Pavan Reddy
Journal: Blood
Blood (2019) 134 (Supplement_1): 3276.
https://doi.org/10.1182/blood-2019-131216
Published: 2019
Journal Articles

Prognostic Significance and Target Potential of Axl in Acute Myeloid Leukemia

Alexander Schultze, M.D., M.Sc., Isabel Ben-Batalla, Ph.D., Michael Heuser, M.D., Kristoffer Weber, Ph.D., Robert Erdmann, Ph.D., Sacha Holland, Ph.D., Stefanie Sawall, Helena Fritz, M.Sc., Marc Tjwa, M.D., Ph.D., Thomas Schmidt, M.D., Walter Fiedler, M.D., Boris Fehse, Ph.D., Bjorn Dahlback, M.D., Klaus Pantel, M.D., Ph.D., Jürgen Krauter, Arnold Ganser, MD, Carsten Bokemeyer, M.D., Sonja Loges, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 940.
https://doi.org/10.1182/blood.V118.21.940.940
Published: 2011
Journal Articles

Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6

Sonja Loges, Thomas Schmidt, Marc Tjwa, Katie van Geyte, Dirk Lievens, Esther Lutgens, Davy Vanhoutte, Delphine Borgel, Stephane Plaisance, Marc Hoylaerts, Aernout Luttun, Mieke Dewerchin, Bart Jonckx, Peter Carmeliet
Journal: Blood
Blood (2010) 115 (11): 2264–2273.
https://doi.org/10.1182/blood-2009-06-228684
Published: 2010
Includes: Supplemental data
Journal Articles

Placental Growth Factor: a Novel, Stromal-Derived Target in Human CML.

Sonja Loges, M.D., Ph.D, Thomas Schmidt, M.D., Christa Maes, Ph.D., Bart Jonckx, Maria Kleppe, Kim De Keersmaecker, Ph.D., Marc Tjwa, M.D., Ph.D., Thomas Schenk, M.D., Karolien Anne Beel, Christiane DeWolf-Peeters, M.D., Geert Carmeliet, M.D., Ph.D., Jan Cools, PhD, Richard E Clark, M.D., Peter Vandenberghe, MD, PhD, Tim H Brummendorf, M.D., Tessa Holyoake, M.D., Andreas Hochhaus, MD, Peter Carmeliet, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 42.
https://doi.org/10.1182/blood.V114.22.42.42
Published: 2009
Journal Articles

A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells

Aya Shibamiya, Karin Hersemeyer, Thomas Schmidt Wöll, Daniel Sedding, Jan-Marcus Daniel, Stefan Bauer, Takatoshi Koyama, Klaus T. Preissner, Sandip M. Kanse
Journal: Blood
Blood (2009) 113 (3): 714–722.
https://doi.org/10.1182/blood-2008-02-137901
Published: 2009
Includes: Supplemental data
Journal Articles

Evaluation of the Role of PlGF and the Therapeutic Potential of Anti-PlGF in BCR/ABL+ Leukemia.

Sonja Loges, M.D., Ph.D, Thomas Schmidt, M.D., Maria Kleppe, Kim De Keersmaecker, Ph.D., Marc Tjwa, M.D., Ph.D., Christa Maes, Ph.D., Christiane DeWolf-Peeters, M.D., Ph.D., Geert Carmeliet, M.D., Ph.D., Jan Cools, Ph.D., Jean-Marie Stassen, Ph.D., Peter Carmeliet, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 1094.
https://doi.org/10.1182/blood.V112.11.1094.1094
Published: 2008
Journal Articles

Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment

Triantafyllos Chavakis, Athanasios Athanasopoulos, Joong-Sup Rhee, Valeria Orlova, Thomas Schmidt-Wöll, Angelika Bierhaus, Andreas E. May, Ilhan Celik, Peter P. Nawroth, Klaus T. Preissner
Journal: Blood
Blood (2005) 105 (3): 1036–1043.
https://doi.org/10.1182/blood-2004-01-0166
Published: 2005